DNAJB6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.463600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.443800E-01
Normal-vs-Stage2
9.979000E-01
Normal-vs-Stage3
4.842000E-01
Normal-vs-Stage4
9.448200E-01
Stage1-vs-Stage2
5.056400E-01
Stage1-vs-Stage3
6.416400E-01
Stage1-vs-Stage4
7.482400E-01
Stage2-vs-Stage3
2.995600E-01
Stage2-vs-Stage4
9.020800E-01
Stage3-vs-Stage4
6.178400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.380800E-01
Normal-vs-AfricanAmerican
8.335200E-01
Normal-vs-Asian
7.473800E-01
Caucasian-vs-AfricanAmerican
7.533600E-01
Caucasian-vs-Asian
5.773600E-01
AfricanAmerican-vs-Asian
5.300400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.976000E-01
Normal-vs-Female
9.921800E-01
Male-vs-Female
5.964200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.185800E-01
Normal-vs-Age(41-60Yrs)
4.478000E-01
Normal-vs-Age(61-80Yrs)
6.456600E-01
Normal-vs-Age(81-100Yrs)
7.579000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.840790E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.251600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.886400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.544600000005E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.048100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.177600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.574400E-01
Normal-vs-Daily Drinker
8.580800E-01
Normal-vs-Weekly Drinker
9.382800E-01
Normal-vs-Occasional Drinker
7.207400E-01
Normal-vs-Social Drinker
5.817400E-01
Non Drinker-vs-Daily Drinker
5.567800E-01
Non Drinker-vs-Weekly Drinker
3.518400E-01
Non Drinker-vs-Occasional Drinker
1.217200E-01
Non Drinker-vs-Social Drinker
7.641800E-02
Daily Drinker-vs-Weekly Drinker
6.569000E-01
Daily Drinker-vs-Occasional Drinker
3.325800E-01
Daily Drinker-vs-Social Drinker
2.121200E-01
Weekly Drinker-vs-Occasional Drinker
7.352000E-01
Weekly Drinker-vs-Social Drinker
5.431200E-01
Occasional Drinker-vs-Social Drinker
6.916200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.392000E-01
Normal-vs-Grade 2
9.930200E-01
Normal-vs-Grade 3
9.877600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.212430E-01
Grade 1-vs-Grade 3
1.364630E-01
Grade 1-vs-Grade 4
9.392000E-01
Grade 2-vs-Grade 3
8.843800E-01
Grade 2-vs-Grade 4
9.930200E-01
Grade 3-vs-Grade 4
9.877600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.050000E-01
Normal-vs-NonDiabetic
9.607800E-01
Diabetic-vs-NonDiabetic
4.959800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.952000E-01
Normal-vs-NoPancreatitis
8.889600E-01
Pancreatitis-vs-NoPancreatitis
1.711200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.291400E-01
Normal-vs-N1
9.510000E-01
N0-vs-N1
7.471900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.506200E-01
Normal-vs-TP53-NonMutant
6.376200E-01
TP53-Mutant-vs-TP53-NonMutant
3.119600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
